Clinical trial · Interventional
Evaluation of the Superficial Cervical Plexus Block in Oncological Throat and Neck Surgery
NCT07110857CI-TRIAL-00093317BCS-ORLnot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This national, prospective, multicenter, randomized study aims to reduce the amount of intravenous morphine (titration + PCA morphine) during the first 24 postoperative hours via a locoregional anesthesia technique in patients undergoing throat and neck cancer surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ENT Cancers | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cervical plexus block with 0.2 % Naropeine | Procedure | — | UNRESOLVED |
| Cervical plexus block with saline placebo | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Naropeine Arm
- description
- Superficial cervical plexus block with 0.2 % ropivacaine (Naropeine)
- interventionNames
- Procedure: Cervical plexus block with 0.2 % Naropeine
- type
- PLACEBO_COMPARATOR
- label
- Placebo Arm
- description
- Superficial cervical plexus block with 0.9 % saline placebo
- interventionNames
- Procedure: Cervical plexus block with saline placebo
Primary outcomes (1)
- measure
- Amount of morphine
- timeFrame
- The first 24 hours postoperatively
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient undergoing ENT cancer surgery with cervicotomy * Adult patient having received oral information from a doctor and signed written consent * Affiliation to a social security scheme, Universal Medical Coverage (CMU) Exclusion Criteria: * Patient refusal * Altered mental faculties or patient unable to give consent * Allergy to local anesthetics * Severe respiratory pathology (altered respiratory function tests with 50% \< FEV1 \< 80%, FEV1/FVC \< 70%, COPD stage 2 or more) * Preoperative SpO2 less than 92% in ambient air * Left heart failure NYHA 3 or more, impaired LVEF \< 30% or less * Lower respiratory infection in the month preceding surgery * History of ENT cancer surgery with cervical lymph node dissection * Pregnant or breastfeeding woman * Patient under AME * Patient under guardianship or reinforced curatorship * Participation in other interventional research
References
Publications (0)
Data not yet available
No reference posted for this study.